A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 years

OBJECTIVE: To compare adalimumab versus etanercept in patients with active rheumatoid arthritis (RA) to test the hypothesis that adalimumab was not inferior to etanercept in terms of drug continuation by a margin of 15% after 52 weeks of treatment. DESIGN: Pragmatic, randomised, parallel group, mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Jobanputra, Paresh, Maggs, Fiona, Deeming, Alison, Carruthers, David, Rankin, Elizabeth, Jordan, Alison C, Faizal, Abdul, Goddard, Carolyn, Pugh, Mark, Bowman, Simon J, Brailsford, Sue, Nightingale, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2012
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532970/
https://www.ncbi.nlm.nih.gov/pubmed/23148339
http://dx.doi.org/10.1136/bmjopen-2012-001395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532970/
https://www.ncbi.nlm.nih.gov/pubmed/23148339
http://dx.doi.org/10.1136/bmjopen-2012-001395

Ejemplares similares